Health Sciences

Here I Am

“They said there was a new oncologist I could get an appointment with—Dr. Stearns—and she and I have been together ever since,” Mohler says, laughing. “I tell Dr. Stearns that when she gets a new office, I want my name on the door too. I got her this far!” (Read the full story)

Can Magnolia Help Break the Link Between Obesity and Breast Cancer?

Stand under the glossy green canopy of a southern magnolia in full bloom, and you’ll be dazzled by this queen tree’s show of hundreds of highly perfumed ivory blossoms, each the size of a teacup. It’s a stunning sight, but for centuries, Magnolia grandiflora has been known for more than its pretty face. The tree contains a pharmacopeia of sorts, yielding chemical compounds that have been used to treat everything from anxiety to heart attack. (Read the full story)

Rare Mutations May Not Always Spur Breast Cancer on Their Own

Results of a new laboratory study suggest that some rare “missense” mutations in the HER2 gene are apparently not — on their own — capable of causing breast cancer growth or spread. In a related finding, the Johns Hopkins research team said such mutations, which are found in about 5 percent of breast cancers, may, thus, also fail to predict response to anti-cancer drugs…(Read the full story)

Researchers Link Organ Transplant Drug to Rise in Rare Lymphoma

A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), appears to protect transplant patients against this rare form of lymphoma. (Read the full story)